metformin/repaglinide (PrandiMet)
Jump to navigation
Jump to search
Indications
- combination therapy for diabetes mellitus type-2
Adverse effects
see metformin, repaglinide
Drug interactions
see metformin, repaglinide
- drug interaction(s) of gemfibrozil with repaglinide
- drug interaction(s) of fluoroquinolones with hypoglycemic agents
Mechanism of action
see metformin, repaglinide
More general terms
Components
References
- ↑ Prescriber's Letter 16(2): 2009 New Drugs Approved by the FDA in 2008 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=250213&pb=PRL (subscription needed) http://www.prescribersletter.com